Salt sensitivity: Concept and pathogenesis

Diabetes Research and Clinical Practice

Volumn 39, Issue SUPPL., 1998, Pages

  González Albarrán, Olga ^a   Ruilope, Luis M ^b   Villa, Eduardo ^a   Robles, Rafael García ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Hypertension; Insulin resistance; Syndrome X

Indexed keywords

INSULIN; SODIUM CHLORIDE;

ADRENERGIC SYSTEM; ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; ESSENTIAL HYPERTENSION; HUMAN; HYPERINSULINISM; INSULIN RESISTANCE; NATRIURESIS; NONHUMAN; OBESITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SALT INTAKE; SYNDROME X;

EID: 0344936689     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(98)00018-7     Document Type: Article

References (133)

1. Dustan H.P., Kirk K.A. Corcoran lecture: The case for and against salt in hypertension. Hypertension. 13:1989;696-705.
2. Muntzel M., Drueke T. A comprehensive review of salt and blood pressure relationship. Am. J. Hypertens. 5:1992;1S-42S.
3. Brown J.J., Lever A.F., Robertson J.I.S. et al. Salt and hypertension (letter). Lancet. 2:1984;456.
4. Carvalho J.J.M., Baruzzi R.G., Howard P.F. et al. Blood pressure in four remote population in the INTERSALT study. Hypertension. 14:1989;238-246.
5. Page L.V., Vandervert D.E., Nader K., Lubin N.K., Page J.R. Blood pressure of Qash'qai pastoral nomads in Iran in relation to culture, diet, and body form. Am. J. Nutr. 34:1981;527-538.
6. Stamler J.S., Rose G., Stamler R., Elliot P., Dyer A., Marmot M. INTERSALT study findings. Public health and medical care implications. Hypertension. 14:1989;570-577.
7. Elliot P. Observational studies of salt and blood pressure. Hypertension. 17 (I):1991;I3-I8.
8. Law M.R., Frost C.D., Wald N.J. By how much does dietary salt reduction lower blood pressure? I. Analysis of observational data among populations. Br. Med. J. 302:1991;811-815.
9. Smith W.C.S., Crombie I.K., Tavendale R.T., Gulland S.K., Tunstall-Pedoe H.D. Urinary electrolyte excretion, alcohol consumption, and blood pressure in the Scottish heart health study. Br. Med. J. 297:1988;329-330.
10. Intersalt: An international study of electrolyte excretion and blood pressure. Results for 24 h urinary sodium and potassium excretion. Br. Med. J. 297:1988;319-328.
11. MacGregor G.A., Best FE, Cam J.M. et al. Double-blind randomized cross-over trial of moderate sodium restriction in essential hypertension. Lancet. 1:1982;351-354.
12. MacGregor G.A., Markandu N.D., Sagnella G.A., Singer D.R.J, Capuccio F.P. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet. 2:1989;1244-1247.
13. Cutler J.A., Follmann D., Elliot P., Suth Y. An overview of randomized trials of sodium reduction and blood pressure. Hypertension. 17:1991;23-27.
14. Mascioli S., Grimm R., Launer C. et al. Sodium chloride raises blood pressure in normotensive subjects. The study of sodium and blood pressure. Hypertension. 17(I):1991;Y21-I26.
15. Hoffman A., Hazebroke A., Valkenburg H.A. A randomized trial of sodium intake and blood pressure in newborn infants. J. Am. Med. Assoc. 250:1983;370-373.
16. The effects of non-pharmacologic interventions on blood pressure of persons with high normal levels. J. Am. Med. Assoc. 267:1992;1213-1220.
17. Stamler R., Stamler J., Gosch F.C., Civinelli J., Fishman J., McKeever P., MacDonald A., Dyer A.R. Primary prevention of hypertension by nutritional-hygienic means. J. Am. Med. Assoc. 262:1989;1801-1807.
18. Grobbee D.E., Hofman A. Does sodium restriction lower blood pressure? Br. Med. J. 293:1986;27-33.
19. Hamet P., Mongeau E., Lambert J. et al. Interaction among calcium, sodium, and alcohol intake as a determinants of blood pressure. Hypertension. 17:1991;I50-I54.
20. Campese V.M. Salt-sensitivity hypertension: Renal and cardiovascular complication. Hypertension. 23:1994;531-550.
21. Weinberger M.H. Sodium sensitivity of blood pressure. Curr. Opin. Nephrol. Hypertens. 2:1993;935-939.
22. Luft F.C., Grim C.E., Higgins J.T. Jr, Weinberger M.H. Differences in response to sodium administration in normotensive white and blacks subjects. J. Lab. Clin. Med. 90:1997;555-562.
23. Kawasaki T., Delea C.S., Bartter F.C., Smith H. The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am. J. Med. 64:1978;194-198.
24. Weinberger M.H., Miller J.Z., Luft F.C., Grim C.E., Fineberg N.S. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 8(II):1986;II127-II134.
25. Sharma A.M., Schattenfroh S., Kribben A., Distler A. Realitbility of salt-sensitivity testing in normotensive subjects. Klin. Woschenschr. 67:1989;632-696.
26. Williams G.H., Dluhy R.G., Lifton R.P. et al. Non-modulation as an intermediate phenotype in essential hypertension. Hypertension. 20:1992;788-796.
27. Ruppert M., Overlack A., Kolloch R., Kraft K., Göbel B., Stumpe K.O. Neurohormonal and metabolic effects of severe and moderate salt restriction in non-obese normotensive adults. J. Hypertens. 11:1993;743-749.
28. Weinberger M.H., Fineberg N.S. Sodium and volumen sensitivity of blood pressure: Age and pressure change over time. Hypertension. 18:1991;67-71.
29. Luft F., Weinberger M.H. Heterogeneous responses to change in dietary salt intake: The salt-sensitivity paradigm. Am. J. Clin. Nutr. 65:1997;612S-617S.
30. Capdevila J.H., Wei S., Yan J. et al. Cytochrome P-450 arachidonic acid epoxygenase. J. Biol. Chem. 267:1992;206-217.
31. Raymond K.H., Lifschitz M.D. Effects of prostaglandin on renal salt and water excretion. Am. J. Med. 80(Suppl 1A):1986;22-33.
32. Roman R.J., Ma Y.H., Frohlich B., Markham B. Clofibrate prevents the development of hypertension in Dalh salt-sensitive rats. Hypertension. 21:1993;985-988.
33. Hilme E., Herlitz H., Gyzander E., Hanzsson L. Urinary kallikrein excretion is low in malignant essential hypertension. J. Hypertens. 10:1992;869-874.
34. Scili A.G., Carretero O.A. Renal kallikrein-kinin system. Kidney Int. 29:1986;120-130.
35. Ader J.L., Tran-van T., Praddaude F. Reduced urinary kallikrein activity in rats developing spontaneous hypertension. Am. J. Physiol. 252:1987;F964-F969.
36. Needleman P., Greenwald J.E. Atriopeptine: A cardiac hormone intimately involved in fluid, electrolyte and blood pressure homeostasis. New Engl. Med. 314:1986;828-834.
37. Sagnella G.A., Markandu N.D., Buckley M.G. et al. Atrial natriuretic peptides in essential hypertension: basal plasma levels and relationship to sodium balance. Can. J. Physiol. Pharmacol. 69:1991;1592-1600.
38. Campese V.M., Raij L. Reduced secretion of atrial natriuretic factor (ANF) in salt-sensitivite patients with essential hypertension. J. Am. Soc. Nephrol. 4:1993;550A.
39. Campese V.M., Tawadrous M., Bigazzi R. et al. Salt intake and plasma atrial natriuretic peptide and nitric oxide in hypertension. Hypertension. 28:1996;335-340.
40. Takenaka T., Suzuki H., Sakamaki Y., Itaya Y., Saruta T. Contribution of prostaglandins to pressure natriuresis in Dalh salt-sensitivite rats. Am. J. Hypertens. 4:1991;489-493.
41. Sullivan J.M. Salt-sensitivity: Definition, conception, methodology and log-term issues. Hypertension. 17:1991;61-68.
42. Luft F.C., Miller J.Z., Grim C.E. et al. Salt-sensitivity and resistance of blood pressure: Age and race as factors in physiological responses. Hypertension. 17:1991;102-108.
43. Weidmann P., Ferrari P. Central role of sodium in hypertension in diabetic subjects. Diabetes Care. 14:1991;220-232.
44. Tuck M.L. Role of salt in the control of blood pressure in obesity and diabetes mellitus. Hypertension. 17:1991;Y135-I142.
45. Weinberger H.M., Miller J.Z., Grim C.E., Fineberg N.S., Christian J.C. Sodium sensitivity and resistance of blood pressure are associated with different haptoglobulin phenotypes. Hypertension. 10:1987;443-446.
46. Campese V.M. Effects of calcium antagonists on deranged modulation of renal function curve in salt-sensitive patients with essential hypertension. Am. J. Cardiol. 62:1988;85G-91G.
47. Wedler B., Brier M.E., Wiersbitzky M. et al. Sodium kinetics in salt-sensitive and salt-resistant normotensive and hypertensive subjects. J. Hypertens. 10:1992;663-669.
48. Campese V.M. Effects of calcium antagonists on darengerd modulation of renal function curve in salt-sensitive patients with essential hypertension. Am. J. Cardiol. 62:1988;85G-91G.
49. Kimura G., Ashida T., Abe H. et al. Sodium sensitive and sodium retaining hypertension. Am. J. Hypertens. 3:1990;398-406.
50. Hollenberg N.K., Moore T., Shoback D., Redgrave J., Rabinowe S., Williams G.H. Abnormal renal sodium handling in essential hypertension. Am. J. Med. 81:1986;412-418.
51. Campese V.M., Parise M., Karubian F., Bigazzi R. Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension. 18:1991;805-812.
52. Alexiwicz J.M., Gaciong Z., Parise M., Karubian F., Massry S.G., Campese V.M. Effects of dietary sodium intake on intracellular calcium in lymphocytes of salt-sensitive hypertension patients. Am. J. Hypertens. 5:1992;536-541.
53. + cotransport activity a marker of salt-sensitivity? Am. J. Hypertens. 6:1993;70A.
54. +-antiport activity and intracellular pH in salt-resistant and salt-sensitive normotensive young men. J. Hypertens. 10(Suppl 4):1992;72.
55. Iwaoka T., Umeda T., Miura F. Renal sodium handling and sodium transport inhibitor in salt-sensitive essential hypertension. Hypertension. 17:1991;780-786.
56. Shimamoto H., Shimamoto Y. Plasma norepinephrine is a major determinant of hemodynamic alterations with sodium loading. J. Hypertens. 10:1992;855-860.
57. Campese V.M., Karubian M.F., Chervu Y., Parise M., Sarkies N., Bigazzi R. Pressor reactivity to norepinephrine and angiotensin in salt-sensitivite hypertensive patients. Hypertension. 21:1993;301-307.
58. Dimsdale J.E., Ziegel M., Mills P., Berry C. Prediction of salt-sensitivity. Am. J. Hypertens. 3:1990;429-435.
59. 2-adrenoceptor density in fibroblast culture correlates with human NaCl sensitivity. Am. J. Physiol. 263:1992;623-627.
60. Gill J.R. Jr, Grossman E., Goldstein D.S. High urinary dopa and low urinary dopamine-to-doparatio in salt-sensitive hypertension. Hypertension. 18:1991;614-621.
61. Hamasaki S.-I., Umeda T., Sato T. Salt-sensitivity and central dopaminergic activity in patients with essential hypertension. Am. J. Hypertens. 4:1991;745-751.
62. Lind L., Lithell H., Gustafsson I.B., Pollare T., Jjunghall S. Metabolic cardiovascular risk factors and sodium sensitivity in hypertensive subjects. Am. J. Hypertens. 5:1992;502-505.
63. Bigazzi R., Bianchi S., Baldari D., Sgherri G., Baldari G., Campese V.M. Microalbuminuria in salt-sensitive patients: A marker for renal and cardiovascular risk factor. Hypertension. 23:1994;195-199.
64. Losito A., Fortunati F., Zampi Y., del Faver A. Imparied renal function reserve and albuminuria in essential hypertension. Br. Med. J. 296:1988;1562-1564.
65. Bianchi S., Bigazzi R., Baldari G., Sgherri G., Campese V.M. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am. J. Hypertens. 7:1994;23-29.
66. Yudkin J.S., Forrest R.D., Jackson C.A. Microalbuminuria as predictor of vascular disease in no-diabetic subjects. Lancet. 2:1988;530-533.
67. Ruilope L.M., Rodicio J.L. Microalbuminuria in clinical practice. Kidney. 4:1995;211-216.
68. Schmieder R.E., Messerli F.H., Garavaglia G.E., Nunez B.D. Dietary salt intake: A determinant of cardiac involvement in essential hypertension. Circulation. 78:1988;951-956.
69. Heimann J.C., Drumond S., Alves A.T.R., Barbato A.J., Dichtchekenian V., Marcondes M. Left ventricular hypertrophy is more marked in salt-sensitive than in salt-resistant hypertension patients. J. Cardiovasc. Pharmacol. 17(2):1991;S122-S124.
70. Bigazzi R., Bianchi S., Baldari G., Campese V.M. Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: Role of insulin. Am. J. Hypertens. 9:1995;24-32.
71. R.N. Bergman, Towards physiological understanding of glucose tolerance: Minimal-model approach, Diabetes (1990) 1512-1533.
72. Himsworth H.P. Diabetes Mellitus. Its differentiation into insulin-sensitive and insulin-insensitive types. Lancet. 1(Part 1):1936;127.
73. Himsworth H.P. The syndrome of diabetes mellitus and its causes. Lancet. 2:1949;465.
74. Himsworth H.P., Kerr R.B. Age and insulin sensitivity. Clin. Sci. 4:1939;153.
75. Reaven G.M. Insulin resistance in noninsulin-dependent diabetes mellitus: Does it exit and can it be measured? Am. J. Med. 74:1983;3-17.
76. Bergman R., Finegood D.T., Ader M. Assessment of insulin sensitivity in vivo. Endocr. Rev. 6:1985;45-86.
77. Martínez F.J., Villa E., Serrano J., García-Robles R. Diagnosis of insulin resistance. Drugs. 46(2):1993;165-171.
78. DeFronzo R.A., Ferranini E. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipemia, and atheroesclerotic cardiovascular disease. Diabetes Care. 14:1991;173-194.
79. Modan M., Halkin H., Almog S. et al. Hyperinsulinemia: A link between hypertension, obesity and glucosa intolerance. J. Clin. Invest. 75:1985;809-817.
80. Higgins M., Kannel W., Garrison R., Pinsky J., Stokes J. Hazards of obesity: The Framinghan experience. Acta Med. Scand. Suppl. 723:1987;23-36.
81. Manolio T.A., Savage P.J., Burke G.L. et al. Association of fasting insulin with blood pressure and lipids in young adults: The CARDIA Study. Ateriosclerosis. 10:1990;430-436.
82. Ferranini E., Buzzigoli G., Bonnadona R. Insulin resistance in essential hypertension. New Engl. J. Med. 317:1987;350-357.
83. Reaven G.M. Banting lecture: Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
84. Davidson M.D. Clinical implications of insulin resistance syndromes. Am. J. Med. 99:1995;420-426.
85. Wellborn T.A., Breckenridge A., Rubinstein A.H., Dollery C., Frase T.R. Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet. 1:1966;1336-1337.
86. Berglund G., Larsson B., Andersson O. et al. Body composition and glucose metabolism in hypertensive middle-aged males. Acta Med. Scand. 200:1976;163-169.
87. Singer P., Gödicke W., Voigt S., Hadju Y., Weiss M. Postprandial hyperinsulinemia in patients with mild essential hypertension. Hypertension. 7:1985;182-186.
88. Ferranini E., Buzzigoli G., Bonadonna R. et al. Insulin resistance in essential hypertension. New Engl. Med. 317:1987;350-357.
89. Shen D.C., Shied S.M., Fuh M.M.T., Wu D.A., Chen Y.D.I., Reaven G.M. Resistance of insulin-stimulated glucose uptake in patients with hypertension. J. Clin. Endocrinol. Metab. 66:1988;580-583.
90. Shen S.W., Reaven G.M., Fahquhar J.W. Comparasion of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J. Clin. Invest. 49:1970;2151-2160.
91. Denker P.S., Pollock V.E. Fasting serum insulin levels in essential hypertension. A meta-analysis. Arch. Intern. Med. 152:1992;1651-1697.
92. Zavaroni Y., Mazza S., Dall'aglio E., Gasparini P., Passeri M., Reaven G.M. Prevalence of hyperinsulinemia in patients with high blood pressure. J. Intern. Med. 231:1992;235-240.
93. Pollare T., Lithell H., Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism. 39:1990;167-174.
94. Rooney D.P., Neely R.D.G., Ennis C.N. et al. Insulin action and hepatic glucose cycling in essential hypertension. Metabolism. 41:1992;317-324.
95. Haffner S.M., Ferraninni E., Hazuda H.P., Stern M.P. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension. 20:1992;38-45.
96. Lissner L., Bengtsson C., Lapidus L., Kristjansson K., Wedel H. Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension. 20:1992;797-801.
97. Alleman Y., Horber F.F., Colombo M. et al. Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents. Lancet. 341:1993;327-331.
98. Jiang X., Srinivasan S.R., Bao W., Berenson G.S. Association of fasting insulin with blood pressure in young individuals. Arch. Intern. Med. 153:1993;323-328.
99. Saad M.F., Lillioja S., Nyomba B.L. et al. Racial differences in the relation between blood pressure and insulin resistance. New Engl. Med. 324:1991;733-739.
100. Ferranini E., Haffner S.M., Stern M. et al. High blood pressure and insulin resistance: Influence of ethnic background. Eur. J. Clin. Invest. 21:1991;280-287.
101. N. Kaplan, Clinical hypertension, (1994) 87-91.
102. Donnelly R., Connell J.M.C. Insulin resistance: Possible role in aetiology and clinical course of hypertension. Clin. Sci. 83:1992;265-275.
103. Hall J.E., Brands M.W., Hilderbrant D.A., Mizelle H.L. Obesity-associated hypertension. Hyperinsulinemia and renal mechanisms. Hypertension. 19:1992;I45-I55.
104. Anderson E.A., Mark A.L. The vasodilator action of insulin. Implications for the insulin hypothesis of hypertension. Hypertension. 21:1993;136-141.
105. Baron A.D., Brechtel-Hook G., Jhonson A., Hardin D. Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension. 21:1993;129-135.
106. O'Brien T., Young W.F. Jr., Pambulo P.J., O'Brien P.C. Hypertension and dyslipemia in patients with insulinoma. Mayo Clin. Proc. 68:1993;141-146.
107. Zimmermann S., Phillips R.A., Dunaif A. et al. Polycystic ovary syndrome: Lack of hypertension despite profound insulin resistance. J. Clin. Endocrinol. Metab. 75:1992;508-513.
108. Landin K., Tengborn L., Smith U. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factor. J. Intern. Med. 229:1991;181-187.
109. Perhadsingh H.A., Szollosi J., Benson S., Hyun W.C. et al. Effects of ciglitazone on blood pressure and intracellular calcium metabolism. Hypertension. 21:1993;1020-1023.
110. DeFronzo R.A., Cooke Cr., Andres R., Faloona G.R., Davis P.J. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J. Clin. Invest. 55:1975;845-855.
111. Rocchini A.P., Key J., Bondie D. et al. Effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. New Engl. J. Med. 321:1989;580-585.
112. Sharma A.M., Ruland K., Spies K.P., Distler A. Salt sensitivity in young normotensive subjects is associated with a hyperinsulinemic response to oral glucose. J. Hypertens. 9:1991;329-335.
113. Rocchini A.P. The relationship of sodium sensitivity to insulin resistance. Am. J. Med. Sci. 307(1):1994;S75-S80.
114. O'Hare J.A. The enigma of insulin resistance and hypertension: Insulin resistance, blood pressure, and the circulation. Am. J. Med. 84:1988;505-510.
115. Dahl L.K., Silver L., Christie R.W. The role of salt in the fall of blood pressure accompanying reduction in obesity. New Engl. J. Med. 258:1958;1186-1192.
116. Reisin E., Abel R., Modan M., Silverberg D.S., Eliahou H., Modan B. Effect of weight loss without salt restriction in the reduction of blood pressure in overweight hypertensive patients. New Engl. J. Med. 298:1978;1-6.
117. Tuck M.I., Sowers J., Dornfeld L., kledzik G., Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity and plasma aldosterone levels in obese patients. New Engl. J. Med. 304:1981;930-933.
118. Rocchini A.P., Moorehead C.P., DeRemer S., Bondie D. Pathogenesis of weight-related changes in blood pressure in dogs. Hypertension. 13:1989;922-928.
119. A.P. Rocchini, C.P. Moorehead, M. London, Salt is a critical for the development of weight gain induced hypertension, Circulation (1990) 87-82.
120. Rocchini A.P., Moorehead C.P., DeRemer S., Goodfriend T.L., Ball D.L. Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II. Hypertension. 15:1990;861-866.
121. Trevisan R., Fioretto P., Semplicini A., Opocher G. et al. Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. Diabetes. 39:1990;289-298.
122. Brands M.W., Hall J.E., Van Vliet B.N., Alonso-galicia M., Herrera G.A., Zappe D. Obesity and hypertension: Roles of hyperinsulinemia, sympathetic nervous system and intrarenal mechanisms. J. Nutr. 125:1995;1725S-1731S.
123. Antishin K., Rocchini A.P., Moorehead C.P., Brown C. Sodium retention in response to an oral glucose load. Pedriatics. 90:1992;442-446.
124. O'Hare J.P., Anderson J.V., Millar N.D., Bloom S.R., Corrall R.J.M. The relationship of the renin-angiotensin-aldosterone system to atrial natriuretic peptide and the natriuresis of volume expansion in diabetics with and without proteinuria. Postgrad. Med. J. 64:1988;35-38.
125. Ditzel J., Brochner-Mortesen J. Tubular reabsorption rates as related to elevated glomerular filtration in diabetic children. Diabetes. 32(Suppl 2):1983;28-33.
126. Nosadini R., Noy G.A., Nattrass M. et al. The metabolic and hormonal response to acute normoglycemia in type 1 diabetes. Diabetologia. 23:1982;220-228.
127. Sharma A.M., Ruland K., Spies K., Distler A. Salt sensitivity in young normotensive subjects is associated with a hyperinsulinemic response to oral glucose. J. Hypertens. 9:1991;329-335.
128. Sharma A.M., Schorr U., Distler A. Insulin resistance in young salt-sensitive normotensive subjects. Hypertension. 21:1993;273-279.
129. Zavaroni Y., Coruzzi P., Bonini L., Mossini G.L. et al. Association between salt sensitivity and insulin concentrations in patients with hypertension. Am. J. Hypertens. 8:1995;855-858.
130. Janssen W.M., Jong P.E., Zeeuw D. Hypertension and renal disease: Role of microalbumnuria. J. Hypertens. 14(5):1996;S173-S177.
131. Zavaroni Y., Bonora E., Pagliara M. et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. New Engl. J. Med. 320:1989;702-706.
132. Després J.P., Lamarche P. et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. New Engl. J. Med. 334:1996;952-957.
133. G. Piedrola, E. Novo, Serrano-Gotarredona, H.F. Escobar-Morreale, E. Villa, J.D. Luna, R. Garcia-Robles, Insulin resistance in patients with a recent diagnosis coronary artery disease, J. Hypertens. 14 (1996) 1477-1482.